Evexia Lifecare promoter group buys 2.93 crore shares in open market
- Shree Saibaba Exim bought 2.93 crore shares of Evexia Lifecare
- Promoter group stake rises to 5.727% from 4.164%
- Acquisition made via open market on BSE on September 16, 2026
- No pledges or encumbrances reported on the acquired shares

*this image is generated using AI for illustrative purposes only.
Shree Saibaba Exim Private Limited, a member of the promoter group of Evexia Lifecare , purchased 2,93,56,550 equity shares in the open market on September 16, 2026. The transaction was executed on the BSE Limited exchange.
The acquisition increases Shree Saibaba Exim’s total holding in Evexia Lifecare to 10,76,36,058 shares, representing 5.727% of the company’s total share capital. Prior to this purchase, the entity held 7,82,79,508 shares, or 4.164%.
Transaction Details
The purchase was disclosed under Regulation 7(2)(a) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Additionally, the acquisition triggered a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
| Metric | Value |
|---|---|
| Acquirer | Shree Saibaba Exim Private Limited |
| Category | Promoter Group |
| Shares Purchased | 2,93,56,550 |
| Stake Increase | 1.563% |
| Post-Acquisition Stake | 5.727% (10,76,36,058 shares) |
| Mode of Acquisition | Open Market |
| Exchange | BSE Limited |
| Date of Acquisition | September 16, 2026 |
Regulatory Disclosures
Evexia Lifecare received the intimation from Shree Saibaba Exim on September 17, 2026. The disclosure confirms that there were no encumbrances, pledges, or convertible securities involved in the transaction. The total equity share capital of Evexia Lifecare remains at 18,77,32,89,995 shares of face value ₹1 each.
No derivatives trading in the securities of the company was reported by the promoter group entity during this period.
Historical Stock Returns for Evexia Lifecar
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.98% | +4.98% | +46.53% | +283.64% | +4.46% | -72.27% |
What strategic rationale is driving the promoter group's decision to increase its stake in Evexia Lifecare amidst current market conditions?
How might this increased promoter holding influence Evexia Lifecare's stock price volatility and investor sentiment in the near term?
Are there plans for further open market acquisitions or potential takeover bids given the regulatory disclosures triggered by this transaction?

































